Literature DB >> 17967600

Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging.

Rasmus Sejersten Ripa1, Jens Christian Nilsson, Yongzhong Wang, Lars Søndergaard, Erik Jørgensen, Jens Kastrup.   

Abstract

BACKGROUND: Knowledge of the natural course after an ST-elevation myocardial infarction (STEMI) treated according to guidelines is limited because comprehensive serial magnetic resonance imaging (MRI) of systolic left ventricular function, edema, perfusion, and infarct size after STEMI has not been undertaken. The aim of this study was to evaluate effects of therapy for STEMI on left ventricular function and perfusion and to test the hypothesis that myocardial perfusion by MRI predicts recovery of left ventricular function.
METHODS: Cine MRI, edema, first-pass perfusion, and late enhancement imaging were performed in 58 patients at day 2 and at 1 and 6 months after successful primary percutaneous coronary stent intervention for STEMI.
RESULTS: Ejection fraction increased 6.3% during the first month (P < .001) and 1.9% from 1 to 6 months (P < .06), indicating a maximal recovery very early after the infarction. The systolic wall thickening in the infarct area almost doubled (P < .001), the perfusion of infarcted myocardium increased approximately 50% (P = .02), and perfusion improved in 72% of patients. Edema decreased with a mean of 2 segments (P < .001) during the first month and another 2.5 segments from 1 to 6 months (P < .001). Infarct size decreased to 1 month (P = .01) and was unchanged from 1 to 6 months (P = .5). Baseline perfusion did not predict improvement in ejection fraction (r = 0.2, P = .2) but did predict regional systolic function (P = .03).
CONCLUSIONS: Left ventricular function, perfusion, and infarct mass recovered substantially after STEMI, with the main part of the change within the first month. First-pass perfusion at rest appeared to predict regional ventricular recovery.

Entities:  

Mesh:

Year:  2007        PMID: 17967600     DOI: 10.1016/j.ahj.2007.06.038

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  26 in total

1.  Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging.

Authors:  Jacob Lønborg; Thomas Engstrøm; Anders B Mathiasen; Niels Vejlstrup
Journal:  Int J Cardiovasc Imaging       Date:  2011-10-05       Impact factor: 2.357

2.  Head to head comparison of quantitative versus visual analysis of contrast CMR in the setting of myocardial stunning after STEMI: implications on late systolic function and patient outcome.

Authors:  Oliver Husser; Vicente Bodi; Juan Sanchis; Julio Nunez; Luis Mainar; Pilar Merlos; Maria P Lopez-Lereu; Jose V Monmeneu; Fabian Chaustre; Eva Rumiz; Günter A J Riegger; Francisco J Chorro; Angel Llacer
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-20       Impact factor: 2.357

3.  Stem cells: REGENT trial-the end of cell therapy for MI?

Authors:  Rasmus S Ripa; Jens Kastrup
Journal:  Nat Rev Cardiol       Date:  2009-09       Impact factor: 32.419

4.  Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling.

Authors:  Adam N Mather; Timothy A Fairbairn; Nigel J Artis; John P Greenwood; Sven Plein
Journal:  Radiology       Date:  2011-08-09       Impact factor: 11.105

5.  Value of cardiac 320-multidetector computed tomography and cardiac magnetic resonance imaging for assessment of myocardial perfusion defects in patients with known chronic ischemic heart disease.

Authors:  Abbas A Qayyum; Jørgen T Kühl; Anders B Mathiasen; Kiril A Ahtarovski; Niels G Vejlstrup; Klaus F Kofoed; Jens Kastrup
Journal:  Int J Cardiovasc Imaging       Date:  2013-05-08       Impact factor: 2.357

6.  Function of remote non-infarcted myocardium after STEMI: analysis with cardiovascular magnetic resonance.

Authors:  Oliver Husser; Fabian Chaustre; Juan Sanchis; Julio Nunez; Jose V Monmeneu; Maria P Lopez-Lereu; Clara Bonanad; Cristina Gomez; Ricardo Oltra; Angel Llacer; Günter A J Riegger; Francisco J Chorro; Vicente Bodi
Journal:  Int J Cardiovasc Imaging       Date:  2012-01-20       Impact factor: 2.357

7.  Circumferential strain acquired by CMR early after acute myocardial infarction adds incremental predictive value to late gadolinium enhancement imaging to predict late myocardial remodeling and subsequent risk of sudden cardiac death.

Authors:  Anthony A Holmes; Jorge Romero; Jeffrey M Levsky; Linda B Haramati; Newton Phuong; Leila Rezai-Gharai; Stuart Cohen; Lina Restrepo; Luis Ruiz-Guerrero; John D Fisher; Cynthia C Taub; Luigi Di Biase; Mario J Garcia
Journal:  J Interv Card Electrophysiol       Date:  2017-11-15       Impact factor: 1.900

8.  TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.

Authors:  Jay H Traverse; Timothy D Henry; Carl J Pepine; James T Willerson; Atul Chugh; Phillip C Yang; David X M Zhao; Stephen G Ellis; John R Forder; Emerson C Perin; Marc S Penn; Antonis K Hatzopoulos; Jeffrey C Chambers; Kenneth W Baran; Ganesh Raveendran; Adrian P Gee; Doris A Taylor; Lem Moyé; Ray F Ebert; Robert D Simari
Journal:  Circ Res       Date:  2017-12-05       Impact factor: 17.367

9.  Usefulness of Q-wave area for threshold-based stratification of global left ventricular myocardial infarct size.

Authors:  Jonathan D Kochav; Peter M Okin; Sean Wilson; Anika Afroz; Alfredo Renilla; Jonathan W Weinsaft
Journal:  Am J Cardiol       Date:  2013-04-20       Impact factor: 2.778

Review 10.  T2-weighted cardiovascular magnetic resonance in acute cardiac disease.

Authors:  Ingo Eitel; Matthias G Friedrich
Journal:  J Cardiovasc Magn Reson       Date:  2011-02-18       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.